Cargando…
Topical Rosiglitazone Is an Effective Anti-Scarring Agent in the Cornea
Corneal scarring remains a major cause of blindness world-wide, with limited treatment options, all of which have side-effects. Here, we tested the hypothesis that topical application of Rosiglitazone, a Thiazolidinedione and ligand of peroxisome proliferator activated receptor gamma (PPARγ), can ef...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733781/ https://www.ncbi.nlm.nih.gov/pubmed/23940641 http://dx.doi.org/10.1371/journal.pone.0070785 |